Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avalon GloboCare (ALBT) EBITDA (2016 - 2026)

Avalon GloboCare filings provide 11 years of EBITDA readings, the most recent being -$4.5 million for Q1 2026.

  • On a quarterly basis, EBITDA fell 80.51% to -$4.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$20.3 million, a 124.83% decrease, with the full-year FY2025 number at -$18.3 million, down 131.16% from a year prior.
  • EBITDA hit -$4.5 million in Q1 2026 for Avalon GloboCare, down from -$2.1 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$253997.0 in Q3 2025 to a low of -$13.5 million in Q2 2025.
  • Median EBITDA over the past 5 years was -$2.4 million (2022), compared with a mean of -$3.5 million.
  • The widest YoY moves for EBITDA: up 84.85% in 2025, down 532.06% in 2025.
  • Avalon GloboCare's EBITDA stood at -$2.4 million in 2022, then tumbled by 300.4% to -$9.6 million in 2023, then surged by 71.46% to -$2.7 million in 2024, then grew by 23.89% to -$2.1 million in 2025, then crashed by 115.79% to -$4.5 million in 2026.
  • The last three reported values for EBITDA were -$4.5 million (Q1 2026), -$2.1 million (Q4 2025), and -$253997.0 (Q3 2025) per Business Quant data.